Vraylar is a prescription drug that’s used to treat certain mental health conditions, such as bipolar I disorder. Vraylar can cause side effects that range from mild to serious. Examples include ...

AbbVie has filed with the FDA to extend the uses of its bipolar disorder therapy Vraylar to include adjunctive ... The dopamine D2/D3 receptor partial agonist has proved to be one of the star ...

Vraylar (cariprazine) is a prescription drug that’s used to treat certain mental health conditions, such as schizophrenia. The drug comes as a capsule that you swallow. It’s usually taken once ...

AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment ... of the fast-growing dopamine D2/D3 receptor partial agonist, one of the star ...

Olfactory receptors are able to detect air-borne odour molecules that enter the nasal cavity and bind to olfactory receptors. The activation of olfactory receptors results in olfactory receptor ...

These receive incoming impulses from other neurones. Information from receptors passes along neurones, as electrical impulses to co-ordinators such as the central nervous system or CNS.

Emma Stoltzfus, 25, a video editor from Omaha, said that she has finally found a way to manage her symptoms with a combination of Effexor (an antidepressant), Vraylar (a drug that improves the ...

The drug is the first approved antipsychotic that targets cholinergic receptors as opposed to dopamine ... Vanda ...

Gift 5 articles to anyone you choose each month when you subscribe. Pathology giant Healius, capitalised at $1.17 billion, has agreed to sell its Lumus radiology business to pan-Asian buyout group ...

Seroquel and Abilify which tend to work by inhibiting D2 dopamine or 5HT-2A Serotonin receptors rather than stimulating muscarinic receptors. All three of these treatments made peak sales of >$5bn ...